Long non-coding RNAs (lncRNAs) are non-coding RNAs with lengths> 200 nt and are
involved in the occurrence and development of cardiovascular diseases (CVDs). Exosomes …

Fibrin, derived from proteins involved in blood clotting (fibrinogen and thrombin), is a
biopolymer with different applications in the health area since it has hemostasis …

Exosomes in cardiovascular theranostics are gaining popularity due to their immense
diagnostic and therapeutic potential generally ascribed to their specific payload and …

Simple Summary The present work focuses on stem-cell assessment as a therapeutic
approach on cardiovascular diseases, both in terms of safety and efficacy. In particular, this …

The human heart has limited regenerative capacity. Therefore, patients often progress to
heart failure after ischemic injury, despite advances in reperfusion therapies generally …

Non-exosomal non-coding RNAs (non-exo-ncRNAs) and exosomal ncRNAs (exo-ncRNAs)
have been associated with the pathological development of myocardial infarction (MI) …

The epicardial administration of therapeutics via the pericardial sac offers an attractive route,
since it is minimally invasive and carries no risks of coronary embolization. The aim of this …

Studies of not only preclinical cardiovascular research but also those of life science,
medical, and pharmacological fields commonly utilize small animal models. However, for the …

The use of experimental animals is quite common in medical research, especially for
pharmaceutical developments and molecular pathway studies. Considering the effects of …

In animal models, human bone marrow mesenchymal stem cell‐derived extracellular
vesicles (MSC‐EV) have been found to have beneficial effects in cardiovascular disease …